Spots Global Cancer Trial Database for gallium ga 68 gozetotide
Every month we try and update this database with for gallium ga 68 gozetotide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer | NCT04750473 | Anatomic Stage ... Invasive Breast... Metastatic Brea... Prognostic Stag... | Computed Tomogr... Fluciclovine F1... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Emory University | |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) | NCT06216249 | Prostate Carcin... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... PSMA PET Scan Questionnaire A... Single Photon E... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer | NCT05547386 | Castration-Resi... Metastatic Pros... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Mayo Clinic | |
| 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer | NCT05176223 | Advanced Hepato... Stage III Hepat... Stage IV Hepato... Unresectable He... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Mayo Clinic | |
| 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer | NCT04762888 | Hepatocellular ... | Computed Tomogr... Gallium Ga 68 G... Magnetic Resona... Positron Emissi... | 18 Years - | Mayo Clinic | |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) | NCT06216249 | Prostate Carcin... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... PSMA PET Scan Questionnaire A... Single Photon E... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer | NCT04279561 | Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| 68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery | NCT03368547 | Prostate Adenoc... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | - | Jonsson Comprehensive Cancer Center | |
| Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer | NCT06200103 | Castration-Resi... Stage IVB Prost... | Biospecimen Col... Bone Scan Clinical Observ... Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... Questionnaire A... Single Photon E... | 18 Years - | Mayo Clinic | |
| Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial | NCT06067269 | Prostate Adenoc... Stage II Prosta... Stage IIIA Pros... Stage IIIB Pros... | Apalutamide Biospecimen Col... Computed Tomogr... Gallium Ga 68 G... Guided Stereota... Multiparametric... Positron Emissi... Questionnaire A... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy | NCT02940262 | Prostate Adenoc... Recurrent Prost... | Gallium Ga 68 G... Laboratory Biom... Positron Emissi... | - | Jonsson Comprehensive Cancer Center | |
| 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer | NCT05176223 | Advanced Hepato... Stage III Hepat... Stage IV Hepato... Unresectable He... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Mayo Clinic | |
| PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer | NCT04310540 | Hepatocellular ... | Biopsy Computed Tomogr... Gallium Ga 68 G... Magnetic Resona... Positron Emissi... | 18 Years - | Mayo Clinic | |
| 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy | NCT04928820 | Biochemically R... Metastatic Mali... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy | NCT05160597 | Prostate Carcin... | Biopsy of Prost... Gallium Ga 68 G... Transrectal Ult... | 18 Years - 90 Years | Jonsson Comprehensive Cancer Center | |
| Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy | NCT02940262 | Prostate Adenoc... Recurrent Prost... | Gallium Ga 68 G... Laboratory Biom... Positron Emissi... | - | Jonsson Comprehensive Cancer Center | |
| Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial | NCT06067269 | Prostate Adenoc... Stage II Prosta... Stage IIIA Pros... Stage IIIB Pros... | Apalutamide Biospecimen Col... Computed Tomogr... Gallium Ga 68 G... Guided Stereota... Multiparametric... Positron Emissi... Questionnaire A... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer | NCT04310540 | Hepatocellular ... | Biopsy Computed Tomogr... Gallium Ga 68 G... Magnetic Resona... Positron Emissi... | 18 Years - | Mayo Clinic | |
| 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer | NCT05547386 | Castration-Resi... Metastatic Pros... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... | 18 Years - | Mayo Clinic | |
| PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer | NCT04310540 | Hepatocellular ... | Biopsy Computed Tomogr... Gallium Ga 68 G... Magnetic Resona... Positron Emissi... | 18 Years - | Mayo Clinic | |
| An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer | NCT04777071 | Biochemically R... Castration-Resi... Prostate Adenoc... Stage IV Prosta... | Computed Tomogr... Gallium Ga 68 G... Positron Emissi... Magnetic Resona... Bone Scan | 18 Years - | University of Washington | |
| Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial | NCT06288113 | Castration-Resi... Stage IVB Prost... | Biospecimen Col... Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... Questionnaire A... Single Photon E... | - | Jonsson Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
